Home Biosimilar Antibodies Others Others antibody Naxitamab (Anti-GD2) For research use only.
Not for use in humans.

Naxitamab (Anti-GD2)

Synonyms: Naxitamab-gqgk; Humanized 3F8; Hu3F8

Naxitamab (Anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers. MW: 145.5 KD.

Naxitamab (Anti-GD2)

Purity & Quality Control

Batch: A248601 Purity: 99% Protein concentration: 9.48mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Naxitamab (Anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers. MW: 145.5 KD.

Product Details

CAS No. 1879925-92-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Naxitamab (Anti-GD2) | Naxitamab (Anti-GD2) supplier | purchase Naxitamab (Anti-GD2) | Naxitamab (Anti-GD2) cost | Naxitamab (Anti-GD2) manufacturer | order Naxitamab (Anti-GD2) | Naxitamab (Anti-GD2) distributor